Inventor
LISTON PETER
CA15 patents
⚠️ This page may combine multiple inventors who share the name “LISTON PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AEGERA THERAPEUTICS INC
8 patentsUS6300492B1Oct 9, 2001
Modulation of IAPs for the diagnosis and antisense treatment of proliferative disease
AEGERA THERAPEUTICS INC33 citations95
US6656704B1Dec 2, 2003
Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
AEGERA THERAPEUTICS INC24 citations92
US6541457B2Apr 1, 2003
Mammalian IAP gene family, primers, probes and detection methods
AEGERA THERAPEUTICS INC16 citations92
US7087584B2Aug 8, 2006
Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
AEGERA THERAPEUTICS INC12 citations91
US6946544B2Sep 20, 2005
XAF genes and polypeptides: methods and reagents for modulating apoptosis
AEGERA THERAPEUTICS INC8 citations73
US6689562B1Feb 10, 2004
Mammalian IAP gene family, primers, probes and detection methods
AEGERA THERAPEUTICS INC4 citations73
US6495339B1Dec 17, 2002
Method of identifying a compound that modulates XAF-mediated apoptosis
AEGERA THERAPEUTICS INC3 citations62
US7067281B2Jun 27, 2006
Mammalian IAP gene family, primers, probes and detection methods
AEGERA THERAPEUTICS INC0 citations52
APOPTOGEN INC
5 patentsUS6133437AOct 17, 2000
Modulation of IAPs for the treatment of proliferative diseases
APOPTOGEN INC68 citations94
US6107041AAug 22, 2000
Detection and modulation of IAPS for the diagnosis and treatment of proliferative disease
APOPTOGEN INC41 citations94
US6107088AAug 22, 2000
XAF genes and polypeptides: methods and reagents for modulating apoptosis
APOPTOGEN INC19 citations92
US6171821B1Jan 9, 2001
XIAP IRES and uses thereof
APOPTOGEN INC43 citations91
US6159709ADec 12, 2000
XIAP IRES and uses thereof
APOPTOGEN INC28 citations91